mlsanityData to 14 Oct 2026

Scalable and Cost-Efficient de Novo Template-Based Molecular Generation

arXiv 2506.19865 ↗First posted 10 Jun 2025q-bio.BM cs.AI cs.LGcited by 5

Not on the map. Why?

Abstract (arXiv)

Template-based molecular generation offers a promising avenue for drug design by ensuring generated compounds are synthetically accessible through predefined reaction templates and building blocks. In this work, we tackle three core challenges in template-based GFlowNets: (1) minimizing synthesis cost, (2) scaling to large building block libraries, and (3) effectively utilizing small fragment sets. We propose Recursive Cost Guidance, a backward policy framework that employs auxiliary machine learning models to approximate synthesis cost and viability. This guidance steers generation toward low-cost synthesis pathways, significantly enhancing cost-efficiency, molecular diversity, and quality, especially when paired with an Exploitation Penalty that balances the trade-off between exploration and exploitation. To enhance performance in smaller building block libraries, we develop a Dynamic Library mechanism that reuses intermediate high-reward states to construct full synthesis trees. Our approach establishes state-of-the-art results in template-based molecular generation.

Key facts. Cited by 5 papers in the map (data through 14 Oct 2026). Builds on 31 of its 54 references that are in the map. First posted on arXiv 10 Jun 2025.

Builds on

31 of 54 references.

References · 31

  1. 2016Gaussian Error Linear Units (GELUs)cited by 3,502
  2. 2022Equivariant Diffusion for Molecule Generation in 3Dcited by 677
  3. 2016Unifying Count-Based Exploration and Intrinsic Motivationcited by 639
  4. 2019Graph Transformer Networkscited by 523
  5. 2021Flow Network based Generative Models for Non-Iterative Diverse Candidate Generationcited by 392
  6. 2016#Exploration: A Study of Count-Based Exploration for Deep Reinforcement Learningcited by 309
  7. 2018GuacaMol: Benchmarking Models for De Novo Molecular Designcited by 297
  8. 2021Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Developmentcited by 264
  9. 2017Count-Based Exploration with Neural Density Modelscited by 257
  10. 2022Trajectory balance: Improved credit assignment in GFlowNetscited by 251
  11. 2018Optimization of Molecules via Deep Reinforcement Learningcited by 200
  12. 2022Biological Sequence Design with GFlowNetscited by 174
19 more
  1. 2022GFlowNets and variational inferencecited by 106
  2. 2018Multi-Objective De Novo Drug Design with Conditional Graph Generative Modelcited by 101
  3. 2022Multi-Objective GFlowNetscited by 101
  4. 2023Towards Understanding and Improving GFlowNet Trainingcited by 75
  5. 2023GFlowNets for AI-Driven Scientific Discoverycited by 63
  6. 2023Equivariant Flow Matching with Hybrid Probability Transportcited by 60
  7. 2022Top-Down Synthesis for Library Learningcited by 58
  8. 2020Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learningcited by 57
  9. 2024Mixed Continuous and Categorical Flow Matching for 3D De Novo Molecule Generationcited by 54
  10. 2021Amortized Tree Generation for Bottom-up Synthesis Planning and Synthesizable Molecular Designcited by 44
  11. 2024RGFN: Synthesizable Molecular Generation Using GFlowNetscited by 41
  12. 2020Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learningcited by 32
  13. 2023Maximum entropy GFlowNets with soft Q-learningcited by 30
  14. 2023nach0: Multimodal Natural and Chemical Languages Foundation Modelcited by 26
  15. 2024Generative Flows on Synthetic Pathway for Drug Designcited by 20
  16. 2024Pessimistic Backward Policy for GFlowNetscited by 14
  17. 2023SILVR: Guided Diffusion for Molecule Generationcited by 9
  18. 2024Generative Active Learning for the Search of Small-molecule Protein Binderscited by 6
  19. 2024Action abstractions for amortized samplingcited by 4

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2025: 2; 2026: 3.

5 papers.